These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 12480574

  • 1. [Superparamagnetic iron oxide-enhanced magnetic resonance imaging of hepatocellular carcinoma in rats].
    Liu X, Xu YK, Huang QL, Wu YK.
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Dec; 22(12):1061-5. PubMed ID: 12480574
    [Abstract] [Full Text] [Related]

  • 2. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
    Castoldi MC, Fauda V, Scaramuzza D, Vergnaghi D.
    Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882
    [Abstract] [Full Text] [Related]

  • 3. Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellular carcinoma in cirrhotic liver.
    Yoo HJ, Lee JM, Lee JY, Kim SH, Kim SJ, Han JK, Choi BI.
    Invest Radiol; 2009 Dec; 44(12):800-7. PubMed ID: 19838119
    [Abstract] [Full Text] [Related]

  • 4. Dual contrast enhanced magnetic resonance imaging of the liver with superparamagnetic iron oxide followed by gadolinium for lesion detection and characterization.
    Kubaska S, Sahani DV, Saini S, Hahn PF, Halpern E.
    Clin Radiol; 2001 May; 56(5):410-5. PubMed ID: 11384141
    [Abstract] [Full Text] [Related]

  • 5. Detection and characterization of hepatocellular carcinoma in rats with liver cirrhosis: diagnostic value of combined use of MR positive and negative contrast agents.
    Guo DM, Qiu TS, Bian J, Liu SF, Wang CZ.
    Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):65-70. PubMed ID: 19208518
    [Abstract] [Full Text] [Related]

  • 6. [Focal liver lesions. A comparison between magnetic resonance under base conditions and after a superparamagentic contrast medium].
    Finazzo M, Midiri M, Gallo C, Bartolotta TV, Luca A.
    Radiol Med; 1998 Jun; 95(6):599-607. PubMed ID: 9717542
    [Abstract] [Full Text] [Related]

  • 7. [Benign hepatic tumors: MRI features before and after administration of superparamagnetic contrast media].
    Bartolotta TV, Midiri M, Galia M, Carcione A, De Maria M, Lagalla R.
    Radiol Med; 2001 Apr; 101(4):219-29. PubMed ID: 11398050
    [Abstract] [Full Text] [Related]

  • 8. Detection of hepatocellular carcinoma (HCC) using super paramagnetic iron oxide (SPIO)-enhanced MRI: Added value of diffusion-weighted imaging (DWI).
    Nishie A, Tajima T, Ishigami K, Ushijima Y, Okamoto D, Hirakawa M, Nishihara Y, Taketomi A, Hatakenaka M, Irie H, Yoshimitsu K, Honda H.
    J Magn Reson Imaging; 2010 Feb; 31(2):373-82. PubMed ID: 20099351
    [Abstract] [Full Text] [Related]

  • 9. Hepatocellular lesions with increased iron uptake on superparamagnetic iron oxide-enhanced magnetic resonance imaging in cirrhosis or chronic hepatitis: comparison of four magnetic resonance sequences for lesion conspicuity.
    Tanabe M, Ito K, Shimizu A, Fujita T, Onoda H, Yamatogi S, Washida Y, Matsunaga N.
    Magn Reson Imaging; 2009 Jul; 27(6):801-6. PubMed ID: 19144487
    [Abstract] [Full Text] [Related]

  • 10. [Magnetic resonance imaging enhanced by superparamagnetic iron oxide particles in detecting lymph node metastasis of tumors: an experimental study].
    Wu YK, Xu YK, Zhang JN, Wu FL, Liu XY, Huang QL.
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Jan; 23(1):62-4. PubMed ID: 12527520
    [Abstract] [Full Text] [Related]

  • 11. Differentiation of well-differentiated hepatocellular carcinomas from other hepatocellular nodules in cirrhotic liver: value of SPIO-enhanced MR imaging at 3.0 Tesla.
    Park HS, Lee JM, Kim SH, Chang S, Kim SJ, Han JK, Choi BI.
    J Magn Reson Imaging; 2009 Feb; 29(2):328-35. PubMed ID: 19161184
    [Abstract] [Full Text] [Related]

  • 12. Superparamagnetic iron oxide (Feridex)-enhanced MRI in diagnosis of focal hepatic lesions.
    Wen G, Zhang XL, Chang RM, Xia Q, Cang P, Zhang Y.
    Di Yi Jun Yi Da Xue Xue Bao; 2002 May; 22(5):451-2. PubMed ID: 12390714
    [Abstract] [Full Text] [Related]

  • 13. Comparison of multi-echo and single-echo gradient-recalled echo sequences for SPIO-enhanced liver MRI at 3 T.
    Choi JS, Kim MJ, Kim JH, Choi JY, Chung YE, Park MS, Kim KW.
    Clin Radiol; 2010 Nov; 65(11):916-23. PubMed ID: 20933647
    [Abstract] [Full Text] [Related]

  • 14. Hypervascular hepatocellular carcinoma in the cirrhotic liver: diffusion-weighted imaging versus superparamagnetic iron oxide-enhanced MRI.
    Chung J, Yu JS, Kim DJ, Chung JJ, Kim JH, Kim KW.
    Magn Reson Imaging; 2011 Nov; 29(9):1235-43. PubMed ID: 21907517
    [Abstract] [Full Text] [Related]

  • 15. A computer-aided diagnostic system to discriminate SPIO-enhanced magnetic resonance hepatocellular carcinoma by a neural network classifier.
    Guo D, Qiu T, Bian J, Kang W, Zhang L.
    Comput Med Imaging Graph; 2009 Dec; 33(8):588-92. PubMed ID: 19656655
    [Abstract] [Full Text] [Related]

  • 16. [Effects of biphasic spiral CT, conventional and iron oxide enhanced MRI on therapy and therapy costs in patients with focal liver lesions].
    Helmberger T, Gregor M, Holzknecht N, Rau H, Scheidler J, Reiser M.
    Rofo; 2000 Mar; 172(3):251-9. PubMed ID: 10778456
    [Abstract] [Full Text] [Related]

  • 17. Superparamagnetic iron oxide nanoparticles stabilized by alginate: pharmacokinetics, tissue distribution, and applications in detecting liver cancers.
    Ma HL, Xu YF, Qi XR, Maitani Y, Nagai T.
    Int J Pharm; 2008 Apr 16; 354(1-2):217-26. PubMed ID: 18191350
    [Abstract] [Full Text] [Related]

  • 18. Imaging of benign hypervascular hepatocellular nodules in alcoholic liver cirrhosis: differentiation from hypervascular hepatocellular carcinoma.
    Kobayashi S, Matsui O, Kamura T, Yamamoto S, Yoneda N, Gabata T, Terayama N, Sanada J.
    J Comput Assist Tomogr; 2007 Apr 16; 31(4):557-63. PubMed ID: 17882031
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of [Gd(Bz-TTDA)]2- as a potential contrast agent in MR imaging of the hepatobiliary system: an animal study.
    Hsu JS, Jaw TS, Liu GC, Wang YM, Chen SH, Kuo YT, Jao JC, Li CW, Tsai KB.
    J Magn Reson Imaging; 2004 Oct 16; 20(4):632-9. PubMed ID: 15390149
    [Abstract] [Full Text] [Related]

  • 20. Conspicuity of liver hemangiomas: short tau inversion recovery, T1, and T2 imaging with gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid.
    Brody JM, Schafer L, Tung GA, Breuer J, Shamsi K.
    J Magn Reson Imaging; 2005 Apr 16; 21(4):391-7. PubMed ID: 15778951
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.